{"url_path":"/sec/camp/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1736730/0001736730-26-000033-index.html","accession_number":"0001736730-26-000033","cik":"0001736730","ticker":"CAMP","issuer_name":"Camp4 Therapeutics Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1736730/0001736730-26-000033-index.html","primary_entity_key":"0001736730","primary_entity_name":"Camp4 Therapeutics Corp"},"word_count":89,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n99.1\n[Press release issued by CAMP4 Therapeutics Corporation on May 14, 2026.](a20260514exhibit991.htm)\n\n99.2\n[Slide presentation, dated May 2026.](a20260514form8-kexhibit9.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nCAMP4 THERAPEUTICS CORPORATION\n\nBy:/s/ Josh Mandel-Brehm\n\nName: Josh Mandel-Brehm\n\nTitle:   President and Chief Executive Officer\n\nDate: May 14, 2026"}